Our oncology experts have identified optimal culture conditions for large-scale, reproducible production of 3D spheroid models that better reflect complex tumor biology by combining relevant tumor, stromal, and immune components. We give you the flexibility to select assay-ready microtissues produced from commonly used cancer cell lines or work with our oncology team to develop custom models designed specifically for your experimental objectives.
“Our oncology team is dedicated to developing 3D tumor models that enable cancer researchers to focus on finding cures—without worrying about spheroid production issues. Through our 3D Select™ Process, we’ve identified optimal culture conditions for large-scale, reproducible production of 3D spheroid models that can be used to assess single-agent or combinatorial efficacy of small molecule, biological, ADC, or immunomodulatory drugs using 3D optimized endpoints.”
PATRICK GUYE, PHD
Chief Scientific Officer